Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chugai Pharmaceutical Co Ltd (CHGCF)
OTHER OTC:CHGCF
Earnings Data
Report Date
Apr 24, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.33Last Year’s EPS
0.3Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Jan 30, 2025
|% Change Since: 19.99%
|Next Earnings Date:Apr 24, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted record-breaking financial results and significant overseas sales growth, coupled with an increase in dividends, showcasing the company's strong performance. However, challenges such as the decline in domestic sales, project discontinuations, and potential biosimilar competition were noted.Company Guidance
During the call, Chugai Pharmaceutical provided guidance on its financial performance for fiscal year 2024 and an outlook for 2025. The company reported that its 2024 results exceeded the revised forecasts, achieving record highs in revenue, operating profit, and net income. Revenue surpassed JPY1 trillion for the third consecutive year, with operating profit exceeding JPY500 billion for the first time and an operating margin of 47.5%. For 2025, Chugai expects to achieve record revenue and profit levels, projecting a revenue increase of 1.7% to JPY1.190 trillion and a core operating profit increase of 2.5% to JPY570 billion, while maintaining a high operating margin. Key growth drivers include strong overseas sales, particularly exports of Hemlibra, and increased revenue from new products and mainstay offerings. The company also highlighted plans to enhance its drug discovery and development processes, including strategic Go/No-Go decisions to optimize its project pipeline.Record-Breaking Financial Performance
Full-year results for 2024 exceeded the revised forecast, with revenue surpassing JPY1 trillion for the third consecutive year and operating profit exceeding JPY500 billion for the first time. The operating margin reached a record high of 47.5%.
Strong Overseas Sales Growth
Overseas sales significantly increased by JPY120.3 billion (28.9%) due to strong export sales of Hemlibra and other products.
Dividend Increase
Reflecting strong performance, a year-end dividend of JPY57 per share was announced, with a total annual dividend of JPY98 per share for 2024, and a forecasted annual dividend of JPY250 per share for 2025.
Pipeline Achievements
Approvals and advancements in the pipeline were notable, including the approval of NEMLUVIO in the U.S. and Europe, and progress in mid-size molecule projects advancing to preclinical stages.
---
CHGCF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CHGCF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Jan 30, 2025 | $38.76 | $32.25 | -16.80% |
| Oct 25, 2024 | $43.37 | $43.18 | -0.44% |
| Jul 25, 2024 | $39.58 | $39.21 | -0.93% |
| Apr 24, 2024 | $33.52 | $32.43 | -3.25% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Chugai Pharmaceutical Co Ltd (CHGCF) report earnings?
Chugai Pharmaceutical Co Ltd (CHGCF) is schdueled to report earning on Apr 24, 2025, TBA Not Confirmed.
What is Chugai Pharmaceutical Co Ltd (CHGCF) earnings time?
Chugai Pharmaceutical Co Ltd (CHGCF) earnings time is at Apr 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CHGCF EPS forecast?
CHGCF EPS forecast for the fiscal quarter 2025 (Q1) is 0.33.
---